Clinical trial
A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven…
NCT00498043 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00498043 |
|---|---|
| Title | A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma |
| Official title | Randomized Phase II Study of Two Associations of Rituximab and Chemotherapy, With a PET -Driven Strategy, in Patients From 18 to 59 With DLBCL CD20+ Lymphoma and 2 or 3 Adverse Prognostic Factors of the Age-adjusted IPI |
| Acronym | LNH2007-3B |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, B-Cell, Large-Cell, Diffuse |
| Intervention type | Drug |
| Interventions | R-CHOP14 induction regimen, R-ACVBP14 induction regimen |
| Enrollment | 222 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2013 |
| Completion | Oct 1, 2013 |
| First posted | Jul 9, 2007 |
| Last update posted | Sep 3, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: